Anti‐epidermal growth factor receptor therapy for glioblastoma in adults

A Lee, M Arasaratnam, DLH Chan… - Cochrane Database …, 2020 - cochranelibrary.com
Background Glioblastoma is an uncommon but highly aggressive type of brain tumour.
Significant gains have been achieved in the molecular understanding and the pathogenesis …

Leptomeningeal melanoma-A case series in the era of modern systemic therapy.

M Arasaratnam, A Hong, B Shivalingam… - Pigment Cell & …, 2017 - europepmc.org
Leptomeningeal melanoma-A case series in the era of modern systemic therapy. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Inter-and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer

M Arasaratnam, M Crumbaker, A Bhatnagar… - Cancer Chemotherapy …, 2019 - Springer
Purpose This study examined the inter-and intra-patient variability in pharmacokinetics of AA
and its metabolites abiraterone and Δ (4)-abiraterone (D4A), and potential contributing …

Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and∆(4)-abiraterone from cancer patients

A Bhatnagar, MJ McKay, M Thaysen-Andersen… - … of Chromatography B, 2019 - Elsevier
Abiraterone acetate is an approved prodrug administered orally in a fixed dose format for the
treatment of metastatic castration-resistant prostate cancer (mCRPC). In vivo, the prodrug is …

Outcomes of retroperitoneal lymph node dissection for testicular cancer by a high volume surgeon from Australia: a case for centralisation

ISC Williams, J Lahoud, H Gurney… - ANZ Journal of …, 2022 - Wiley Online Library
Background There are few studies examining retroperitoneal lymph node dissection
(RPLND) for testicular cancer in Australia. This study examines the perioperative outcomes …

Nivolumab in the treatment of advanced renal cell carcinoma

M Arasaratnam, H Gurney - Future Oncology, 2018 - Future Medicine
Renal cell carcinoma (RCC) has typically been considered an immunogenic malignancy
with responses seen to IL-2 and IFN-α. Response rates, however, were low and at the cost …

Drug reaction with eosinophilia and systemic symptoms in metastatic basal cell carcinoma treated with vismodegib.

CL Thomas, M Arasaratnam, G Carlos… - Australasian …, 2017 - search.ebscohost.com
The article presents a case study of a 68-year-old man with metastatic basal cell carcinoma
(BCC) with symptoms and signs consistent with a drug reaction of eosinophilia and systemic …

Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma

A Bhatnagar, MJ McKay, M Arasaratnam… - Journal of mass …, 2020 - Wiley Online Library
Paper spray ionization (PSI) is a direct, fast, and low‐cost ambient ionization technique
which may have clinical utility for qualitative and quantitative analysis of therapeutic drugs …

Patterns of care and outcomes of men with germ cell tumors in a high‐volume Australian center

M Arasaratnam, B Balakrishnar… - Asia‐Pacific Journal …, 2022 - Wiley Online Library
Aim To evaluate disease presentation, treatment practices, and outcomes of patients with
germ cell tumor (GCT) treated in a high‐volume cancer center in Australia. Methods This is a …

Continuing cabazitaxel beyond 10 cycles for metastatic castrate-resistant prostate cancer: is there a benefit?

ALM Loma, M Arasaratnam, H Gurney - European Journal of Hospital …, 2021 - ejhp.bmj.com
Aim Cabazitaxel prolongs survival in patients with metastatic castration-resistant prostate
cancer in the postdocetaxel setting. We investigate the benefit of continuing cabazitaxel …